Incidence of Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive Disorder
- Conditions
- Major Depressive DisorderMetabolic SyndromeThyroid Dysfunction
- Registration Number
- NCT01682785
- Lead Sponsor
- Chiang Mai University
- Brief Summary
Aim 1 is to study prevalence and 1 year incidence of metabolic syndrome in major depressive disorder and factors correlation.
Aim 2 is to study prevalence and 1 year incidence of thyroid dysfunction in major depressive disorder and factors correlation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
- patient with major depressive disorder
- age over 18 years
Exclusion Criteria
- subject who cannot give information.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link metabolic syndrome and thyroid dysfunction in major depressive disorder patients?
How does the incidence of metabolic syndrome in NCT01682785 compare to standard-of-care treatment outcomes for MDD?
Are there specific biomarkers that correlate with the development of metabolic syndrome in MDD patients over a year?
What adverse events are associated with thyroid dysfunction in major depressive disorder and how are they managed?
What combination therapies or drugs target both metabolic syndrome and thyroid dysfunction in MDD patients?